Instil Bio Inc (TIL)
11.58
+0.35
(+3.12%)
USD |
NASDAQ |
May 10, 16:00
11.22
-0.36
(-3.11%)
After-Hours: 20:00
Instil Bio Total Liabilities (Quarterly): 99.80M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 99.80M |
| September 30, 2023 | 106.25M |
| June 30, 2023 | 111.79M |
| March 31, 2023 | 116.02M |
| December 31, 2022 | 118.52M |
| September 30, 2022 | 122.15M |
| June 30, 2022 | 110.20M |
| Date | Value |
|---|---|
| March 31, 2022 | 56.38M |
| December 31, 2021 | 54.78M |
| September 30, 2021 | 45.98M |
| June 30, 2021 | 37.20M |
| March 31, 2021 | 30.99M |
| December 31, 2020 | 358.61M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.99M
Minimum
Mar 2021
358.61M
Maximum
Dec 2020
105.28M
Average
106.25M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 325.63M |
| Shareholders Equity (Quarterly) | 225.83M |